Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of heme arginate (Normosang) on human heme oxygenase activity and adenosine-induced vasodilation
2008-006922-32Phase 2Terminated
- Sponsor
- Radboud University Medical Center
- Start
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of heme arginate in atherosclerotic disease and type 2 diabetes mellitus (T2DM), sponsored by Radboud University Medical Center. Primary endpoint: HO-1 mRNA level in PBMCs. Started Oct 2008; status: terminated.
02
Drugs
heme arginate
03
Conditions
atherosclerotic diseasetype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2008-006922-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006922-32.